Skip to main content

AbbVie Inc.

For the period ended Dec 31, 2025. Filed Feb 20, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 20, 2026

ABBV$293.30+0.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, AbbVie Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AbbVie Inc.
By:/s/ ROBERT A. MICHAEL
Name:Robert A. Michael
Title:Chairman of the Board and Chief Executive Officer
Date:February 20, 2026

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of AbbVie Inc. on February 20, 2026 in the capacities indicated below.

/s/ ROBERT A. MICHAEL/s/ SCOTT T. REENTS
Robert A. MichaelChairman of the Board and Chief Executive Officer (Principal Executive Officer)Scott T. ReentsExecutive Vice President, Chief Financial Officer(Principal Financial Officer)
/s/ DAVID R. PURDUE/s/ ROBERT J. ALPERN, M.D.
David R. PurdueSenior Vice President, Controller(Principal Accounting Officer)Robert J. Alpern, M.D.Director of AbbVie Inc.
/s/ ROXANNE S. AUSTIN/s/ WILLIAM H.L. BURNSIDE
Roxanne S. AustinDirector of AbbVie Inc.William H.L. BurnsideDirector of AbbVie Inc.
/s/ JENNIFER L. DAVIS/s/ THOMAS J. FALK
Jennifer L. DavisDirector of AbbVie Inc.Thomas J. FalkDirector of AbbVie Inc.
/s/ THOMAS C. FREYMAN/s/ BRETT J. HART
Thomas C. FreymanDirector of AbbVie Inc.Brett J. HartDirector of AbbVie Inc.
/s/ MELODY B. MEYER/s/ SUSAN E. QUAGGIN, M.D.
Melody B. MeyerDirector of AbbVie Inc.Susan E. Quaggin, M.D.Director of AbbVie Inc.
/s/ EDWARD J. RAPP/s/ REBECCA B. ROBERTS
Edward J. RappDirector of AbbVie Inc.Rebecca B. RobertsDirector of AbbVie Inc.
/s/ FREDERICK H. WADDELL
Frederick H. WaddellDirector of AbbVie Inc.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.